Journal
CURRENT PROBLEMS IN CARDIOLOGY
Volume 49, Issue 2, Pages -Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.cpcardiol.2023.102189
Keywords
Cardiovascular disease; cGAS; Inflammatory response; Myocardial; STING; Therapeutic
Categories
Ask authors/readers for more resources
Inflammation plays a crucial role in cardiovascular diseases (CVD) and the cGAS-STING signaling pathways have been increasingly activated in these diseases. Recent studies provide new insights and characterizations of this pathway in the development of CVD.
It is now widely accepted that inflammation is critical in cardiovascular diseases (CVD). Here, studies are being conducted on how cyclic GMP-AMP synthase (cGAS), a component of innate immunity's DNA-sensing machinery, communicates with the STING receptor, which is involved in activating the immune system's antiviral response. Significantly, a growing body of research in recent years highlights the strong activation of the cGAS-STING signalling pathways in several cardiovascular diseases, such as myocardial infarction, heart failure, and myocarditis. This developing collection of research emphasises these pathways' crucial role in initiating and advancing cardiovascular disease. In this extensive narrative, we explore the role of the cGASSTING pathway in the development of CVD. We elaborate on the basic mechanisms involved in the onset and progression of CVD. This review explores the most recent developments in the recognition and characterization of cGAS-STING pathway. Additionally, it considers the field's future prospects while examining how cGAS-STING pathway might be altered and its clinical applications for cardiovascular diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available